RhumbLine Advisers’s Aspen Aerogels ASPN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$287K Sell
83,999
-5,319
-6% -$17.9K ﹤0.01% 2926
2025
Q4
$253K Sell
89,318
-21,414
-19% -$110K ﹤0.01% 3062
2025
Q3
$771K Sell
110,732
-2,774
-2% -$19.6K ﹤0.01% 2405
2025
Q2
$672K Buy
113,506
+22,541
+25% +$130K ﹤0.01% 2478
2025
Q1
$581K Sell
90,965
-2,079
-2% -$20K ﹤0.01% 2479
2024
Q4
$1.11M Buy
93,044
+2,554
+3% +$43.5K ﹤0.01% 2203
2024
Q3
$2.51M Sell
90,490
-2,736
-3% -$68.5K ﹤0.01% 1784
2024
Q2
$2.22M Buy
93,226
+11,205
+14% +$263K ﹤0.01% 1829
2024
Q1
$1.44M Buy
82,021
+2,239
+3% +$33K ﹤0.01% 2073
2023
Q4
$1.26M Buy
79,782
+3,665
+5% +$37.8K ﹤0.01% 2143
2023
Q3
$655K Buy
76,117
+1,861
+3% +$13.2K ﹤0.01% 2441
2023
Q2
$586K Buy
74,256
+25,479
+52% +$177K ﹤0.01% 2590
2023
Q1
$363K Buy
48,777
+10,344
+27% +$103K ﹤0.01% 2551
2022
Q4
$453K Buy
38,433
+1,421
+4% +$16.2K ﹤0.01% 2511
2022
Q3
$341K Buy
37,012
+6,028
+19% +$73K ﹤0.01% 2674
2022
Q2
$306K Buy
30,984
+8,613
+39% +$174K ﹤0.01% 2740
2022
Q1
$771K Buy
22,371
+2,664
+14% +$86.5K ﹤0.01% 2235
2021
Q4
$981K Buy
19,707
+119
+0.6% +$6.27K ﹤0.01% 2223
2021
Q3
$901K Buy
19,588
+2,067
+12% +$81.9K ﹤0.01% 2270
2021
Q2
$524K Sell
17,521
-7,655
-30% -$156K ﹤0.01% 2546
2021
Q1
$512K Sell
25,176
-1,395
-5% -$29.4K ﹤0.01% 2479
2020
Q4
$443K Buy
26,571
+5,369
+25% +$70.6K ﹤0.01% 2487
2020
Q3
$232K Sell
21,202
-4,319
-17% -$34.2K ﹤0.01% 2629
2020
Q2
$168K Buy
+25,521
New +$164K ﹤0.01% 2831

Other funds holding ASPN

RhumbLine Advisers's ASPN Position: Q1 2026 in Review

RhumbLine Advisers reduced its Aspen Aerogels (ASPN) stake by 6% in Q1 2026, selling an estimated $17.9K and leaving 83,999 shares worth $287K. The position accounts for ﹤0.01% of the portfolio, ranked #2926.

RhumbLine Advisers first reported a position in ASPN in Q2 2020 and has held it in 24 quarters since. The position peaked at $2.51M in Q3 2024. 166 funds tracked by Wall St. Rank hold ASPN as of Q1 2026.

  • RhumbLine Advisers held 83,999 shares of Aspen Aerogels worth $287K as of Q1 2026.
  • RhumbLine Advisers sold 5,319 Aspen Aerogels shares in Q1 2026, an estimated $17.9K.
  • Aspen Aerogels made up ﹤0.01% of RhumbLine Advisers's portfolio in Q1 2026, its #2926 holding.
  • RhumbLine Advisers first reported a position in Aspen Aerogels in Q2 2020 and has held it in 24 quarters since.
  • RhumbLine Advisers's Aspen Aerogels position peaked at $2.51M in Q3 2024.
  • 166 funds tracked by Wall St. Rank held Aspen Aerogels as of Q1 2026.

Based on RhumbLine Advisers's 13F filing for Q1 2026, filed 12 May 2026.